SAI LIFE SCIENCES LIMITED (SAILIFE) Share Price Hits Fresh 52-Week High

SAI LIFE SCIENCES LIMITED Share Price hits a fresh 52-week high at Rs 1,360, rising 1.75% today. Market cap stands at Rs 27,940.13 Cr.

SAI LIFE SCIENCES LIMITED Share Price reached a fresh 52-week high of Rs 1,360 today, marking a 1.75% increase from the previous close of Rs 1,331.45. The stock opened at Rs 1,356.7 and fluctuated between a low of Rs 1,333.7 and the new high. The company's market capitalisation is Rs 27,940.13 Cr, reflecting its significant presence in the healthcare sector. This milestone highlights investor interest and positions the company prominently within its industry.

SAI LIFE SCIENCES LIMITED Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,354.8
Previous Close	Rs 1,331.45
Today's Change	+Rs 23.35 (+1.75%)
Day Open	Rs 1,356.7
Fresh 52-Week High	Rs 1,360
Day Low	Rs 1,333.7
Current Volume	3,489
Turnover	Rs 0.47 crore
Market Capitalisation	Rs 27,940.13 crore

SAI LIFE SCIENCES LIMITED (SAILIFE) traded at Rs 1,354.8. versus the previous close of Rs 1,331.45, a rise of 1.75%. The stock opened at Rs 1,356.7, reached Rs 1,360, touched Rs 1,333.7. Reported volume was 3,489.

Today's trading session saw SAI LIFE SCIENCES LIMITED Share Price rise to a new 52-week high of Rs 1,360. The stock opened at Rs 1,356.7, with a previous close of Rs 1,331.45, resulting in a day change of Rs 23.35 or 1.75%. The day's turnover was Rs 0.47 Cr with a volume of 3,489 shares, indicating moderate trading activity. This price action suggests a positive sentiment among investors, driving the stock to its yearly peak.

SAI LIFE SCIENCES LIMITED (SAILIFE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 27,940.13 crore
P/E Ratio	39.39x
P/B Ratio	7.98x
ROE	28.21%
ROCE	26.35%

SAI LIFE SCIENCES LIMITED was valued at a P/E ratio of 39.39x, a P/B ratio of 7.98x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	39.39x
Benchmark Median P/E	20.89x
Benchmark Average P/E	73.74x
Benchmark P/E Range	0x to 3,364.06x
Company P/B Ratio	7.98x
Benchmark Median P/B	1.9x
Company ROE	28.21%
Benchmark Median ROE	10.92%
Company ROCE	26.35%
Benchmark Median ROCE	13.29%
Company Market Capitalisation	Rs 27,940.13 crore
Benchmark Median Market Cap	Rs 139.24 crore

SAI LIFE SCIENCES LIMITED (SAILIFE) is classified under sector: Healthcare.

SAI LIFE SCIENCES LIMITED (SAILIFE) has a P/E ratio of 39.39x, which is above the benchmark median of 20.89x, a difference of +88.56%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

SAI LIFE SCIENCES LIMITED (SAILIFE) has a ROE of 28.21%, which is above the benchmark median of 10.92%, a difference of +158.33%. SAI LIFE SCIENCES LIMITED (SAILIFE) has a ROCE of 26.35%, which is above the benchmark median of 13.29%, a difference of +98.27%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Kwality Pharmaceuticals Ltd.	KPL	2,683.28	39.39	7.98	28.21	26.35
Beta Drugs Ltd.	BETA	2,474.26	62.88	9.95	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,421.1	34.54	6.99	-2.6	16.92
Sai Parenteral's Ltd.	SAIPARENT	2,416.82	171.93	3.18	13.9	12.97
Hester Biosciences Ltd.	HESTERBIO	2,111.45	15.25	4.57	16.17	14.12

SAI LIFE SCIENCES LIMITED (SAILIFE) has a P/E ratio of 39.39x compared with the displayed peer median of 39.39x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 16.17% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. SAI LIFE SCIENCES LIMITED (SAILIFE) has a market capitalisation of Rs 27,940.13 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching SAI LIFE SCIENCES LIMITED

• Achieved a fresh 52-week high at Rs 1,360.
• Strong fundamental performance with high ROE and ROCE.
• Premium valuation compared to sector medians.
• Dominant market position within the healthcare sector.

About SAI LIFE SCIENCES LIMITED

SAI LIFE SCIENCES LIMITED is a prominent player in the healthcare sector, focusing on the development and manufacturing of pharmaceutical products. The company leverages its expertise in research and development to deliver high-quality healthcare solutions. With a robust market presence and a commitment to innovation, SAI LIFE SCIENCES LIMITED continues to expand its footprint in the industry.

Track SAI LIFE SCIENCES LIMITED Share Price on Univest

Use SAI LIFE SCIENCES LIMITED (SAILIFE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors can track SAI LIFE SCIENCES LIMITED Share Price, technical indicators, fundamental ratios, shareholding pattern, 52-week levels, and market insights on Univest.

Frequently Asked Questions

What is the current share price of SAI LIFE SCIENCES LIMITED?

Ans. The current share price of SAI LIFE SCIENCES LIMITED is Rs 1,354.8, reflecting a 1.75% increase from the previous close. The stock moved 1.75% during the session. The intraday range extended from Rs 1,333.7 to Rs 1,360.

What is the market capitalisation of SAI LIFE SCIENCES LIMITED?

Ans. The market capitalisation of SAI LIFE SCIENCES LIMITED is Rs 27,940.13 Cr, positioning it as a significant player in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 39.39x.

How does SAI LIFE SCIENCES LIMITED's P/E ratio compare to the sector?

Ans. SAI LIFE SCIENCES LIMITED's P/E ratio of 39.39 is above the sector median of 20.89, indicating a higher valuation compared to its peers. The company trades at a P/E ratio of 39.39x.

What is the P/B ratio of SAI LIFE SCIENCES LIMITED?

Ans. The P/B ratio of SAI LIFE SCIENCES LIMITED is 7.98, which is significantly higher than the sector median of 1.9. The company trades at a P/E ratio of 39.39x. Its P/B ratio is 7.98x.

What are the ROE and ROCE of SAI LIFE SCIENCES LIMITED?

Ans. SAI LIFE SCIENCES LIMITED has an ROE of 28.21% and a ROCE of 26.35%, both indicating strong profitability and efficient capital use. ROE stands at 28.21%. ROCE stands at 26.35%.

Who are the peers of SAI LIFE SCIENCES LIMITED?

Ans. Peers of SAI LIFE SCIENCES LIMITED include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., and Dr Agarwals Eye Hospital Ltd., among others. Comparable listed companies include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., Dr Agarwals Eye Hospital Ltd.

What is the sector benchmark for SAI LIFE SCIENCES LIMITED?

Ans. The sector benchmark for SAI LIFE SCIENCES LIMITED includes a P/E median of 20.89 and a P/B median of 1.9, among other metrics. The stock belongs to the Healthcare sector.

What is the 52-week high of SAI LIFE SCIENCES LIMITED?

Ans. The 52-week high of SAI LIFE SCIENCES LIMITED is Rs 1,360, achieved today. The stock moved 1.75% during the session. The intraday range extended from Rs 1,333.7 to Rs 1,360.

How does SAI LIFE SCIENCES LIMITED's market cap compare to its peers?

Ans. SAI LIFE SCIENCES LIMITED's market cap of Rs 27,940.13 Cr is substantially higher than its peers, indicating a dominant market position. The company operates in the Healthcare sector. Its P/E ratio is 39.39x.